Stocks and Investing Stocks and Investing
Thu, December 10, 2020
Wed, December 9, 2020

Andrew Berens Maintained (AGIO) at Buy with Decreased Target to $61 on, Dec 9th, 2020


Published on 2024-10-27 14:57:44 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Decreased Target from $67 to $61 on, Dec 9th, 2020.

Andrew has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Peter Lawson of "Barclays" Upgraded from Hold to Buy and Held Target at $46 on, Thursday, October 22nd, 2020
  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $70 on, Monday, October 19th, 2020
Contributing Sources